A sub-analysis of available baseline and surgical samples (n = 10), suggested that neoadjuvant chemoimmunotherapy results in elevated CD3+ and CD8+ TILs in the stroma and tumor after neoadjuvant treatment, implying that neoadjuvant chemoimmunotherapy causes immune activation. Here, CD8A is linked to neoplasm.